Felice Rivellese - Concepedia

Author

Felice Rivellese

Also Known As

Christopher Ritchlin, F Rivellese, F. Rivellese, Felice Rivellese, Myles Lewis, Rivellese, F., Rivellese, Felice, the R4RA collaborative group

126

Publications

5.8K

Citations

H-Index

Concepts

All Affiliations

Queen Mary University of London William Harvey Research Institute Barts Health NHS Trust University of Naples Federico II Leiden University Medical Center

About

Felice Rivellese is an author at Queen Mary University of London specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	467
2	Cell Biology	5	5	456
3	Public Health	2	2	38
4	Allergy	2	2	82
5	Cellular Physiology	1	1	17

Felice Rivellese

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update Josef S Smolen, Robert Landewé, Sytske Anne Bergstra, Annals of the Rheumatic Diseases	2022	1.6K
Molecular Portraits of Early Rheumatoid Arthritis Identify Clinical and Treatment Response Phenotypes Myles Lewis, Michael R. Barnes, Kevin Blighe, Cell Reports	2019	380
Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes Fan Zhang, A. Helena Jonsson, Aparna Nathan, Nature	2023	323
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial Frances Humby, Patrick Durez, Maya H Buch, The Lancet	2021	285
Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells Simon Rauber, Markus Luber, Stefanie Weber, Nature Medicine InflammationCytokineAutoimmune DiseaseInnate Lymphoid CellsImmunology	2017	278
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial Felice Rivellese, Anna E. A. Surace, Katriona Goldmann, Nature Medicine	2022	240
Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjögren's syndrome with ectopic germinal centres and MALT lymphoma Elena Pontarini, William Murray‐Brown, Cristina Croia, Annals of the Rheumatic Diseases	2020	175
Plasma ACE2 predicts outcome of COVID-19 in hospitalized patients Tue Wenzel Kragstrup, Helene Søgaard Singh, Ida Grundberg, PLoS ONE	2021	120
Synovial tissue signatures enhance clinical classification and prognostic/treatment response algorithms in early inflammatory arthritis and predict requirement for subsequent biological therapy: results from the pathobiology of early arthritis cohort (PEAC) Gloria Lliso-Ribera, Frances Humby, Myles Lewis, Annals of the Rheumatic Diseases	2019	112
Heterogeneity of Human Mast Cells With Respect to MRGPRX2 Receptor Expression and Function Gilda Varricchi, Antonio Pecoraro, Stefania Loffredo, Frontiers in Cellular Neuroscience	2019	103

Page 1